Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Triple Negative Breast Cancer Malignancies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT05088057
What this trial is testing

Neoadjuvant Camrelizumab Plus Chemotherapy in Triple Negative Breast Cancer

Who this might be right for
Triple Negative Breast Cancer (TNBC)
Aiping Shi 30
Testing effectiveness (Phase 2)Looking for participantsNCT06134375
What this trial is testing

Tetrathiomolybdate (TM) Plus Capecitabine

Who this might be right for
Triple Negative Breast CancerResidual Disease
Dartmouth-Hitchcock Medical Center 204
Early research (Phase 1)Study completedNCT00707707
What this trial is testing

Phase I/II Study of AZD2281 Given in Combination With Paclitaxel in Metastatic Triple Negative Breast Cancer

Who this might be right for
Breast CancerTriple Negative Breast CancerMetastatic Breast Cancer
AstraZeneca 19
Not applicableLooking for participantsNCT06349512
What this trial is testing

68Ga-FAPI-46 PET/CT for Predicting Histological Response in Triple-negative Breast Cancer (FAP-IT)

Who this might be right for
Triple Negative Breast Cancer
Institut Curie 60
Early research (Phase 1)Study completedNCT02482311
What this trial is testing

Safety, Tolerance, PK, and Anti-tumour Activity of AZD1775 Monotherapy in Patients With Advanced Solid Tumours

Who this might be right for
Ovarian Cancer, TNBC, SCLC, Other Solid Tumours
AstraZeneca 92
Not applicableLooking for participantsNCT06991790
What this trial is testing

Sacituzumab Govitecan + Toripalimab as First - Line Therapy for Advanced Triple - Negative Breast Cancer and Biomarker Exploration

Who this might be right for
TNBC
Peking University Cancer Hospital & Institute 51
Large-scale testing (Phase 3)UnknownNCT04907344
What this trial is testing

Study of Camrelizumab Plus Chemotherapy as Neoadjuvant Therapy in Participants With Triple Negative Breast Cancer (TNBC)

Who this might be right for
Triple Negative Breast Cancer
Tianjin Medical University Cancer Institute and Hospital 420
Not applicableLooking for participantsNCT05314114
What this trial is testing

Selective Omission of Axillary Surgery in Triple-negative and HER2-positive Breast Cancer After NACT

Who this might be right for
Breast Cancer Female
Peking University 136
Testing effectiveness (Phase 2)Study completedNCT01421472
What this trial is testing

A Trial of Preoperative MM-121 With Paclitaxel in HER2-negative Breast Cancer

Who this might be right for
ER Positive, Her2 Negative Breast Cancer PatientsTriple Negative Breast Cancer Patients
Merrimack Pharmaceuticals 196
Early research (Phase 1)Study completedNCT03542175
What this trial is testing

Rucaparib Administered With Radiation in Patients With Triple Negative Breast Cancer With an Incomplete Response Following Chemotherapy

Who this might be right for
Breast Cancer
Memorial Sloan Kettering Cancer Center 31
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06819319
What this trial is testing

SHR-A2102 Combined With Adebrelimab as Neoadjuvant Therapy for Early Triple-Negative Breast Cancer

Who this might be right for
TNBC - Triple-Negative Breast Cancer
Henan Cancer Hospital 52
Large-scale testing (Phase 3)Looking for participantsNCT06081244
What this trial is testing

NeoAdj. Therapy Comparing Sacituzumab Govitecan (SG) vs. SG+Pembrolizumab in Low-risk, Triple-neg. EBC (ADAPT-TN-III)

Who this might be right for
Triple Negative Breast Cancer
Women's Cancer Study Group GmbH 348
Early research (Phase 1)Looking for participantsNCT07646106
What this trial is testing

THE-0504 in Patients With Solid Tumors

Who this might be right for
Small Cell Lung Cancer (SCLC)Colorectal Carcinoma (CRC)Gastric Cancer (GC)+2 more
Thena Biotech S.r.l. 30
Testing effectiveness (Phase 2)Study completedNCT03106415
What this trial is testing

Pembrolizumab and Binimetinib in Treating Patients With Locally Advanced or Metastatic Triple Negative Breast Cancer

Who this might be right for
Breast AdenocarcinomaMetastatic Triple-Negative Breast CarcinomaStage III Breast Cancer AJCC v7+4 more
Mayo Clinic 23
Very early researchActive Not RecruitingNCT05333874
What this trial is testing

CIPHER Study: Pilot Study to Study the Role of ctDNA in Triple Negative and HER2 Positive Early Stage

Who this might be right for
Breast Cancer, Early-Onset
Rutgers, The State University of New Jersey 34
Testing effectiveness (Phase 2)Active Not RecruitingNCT04243616
What this trial is testing

Cemiplimab in High-risk or Locally Advanced Luminal and Triple Negative Breast Cancer

Who this might be right for
Invasive Breast Cancer
Medical College of Wisconsin 36
Testing effectiveness (Phase 2)Study completedNCT05007106
What this trial is testing

MK-7684A With or Without Other Anticancer Therapies in Participants With Selected Solid Tumors (MK-7684A-005) (KEYVIBE-005)

Who this might be right for
Uterine Cervical NeoplasmsEndometrial NeoplasmsSquamous Cell Carcinoma of Head and Neck+8 more
Merck Sharp & Dohme LLC 613
Testing effectiveness (Phase 2)Study completedNCT02000882
What this trial is testing

STAR Cape+BKM120 MBC With Brain Met

Who this might be right for
Brain MetastasesBreast CancerMetastatic Breast Cancer
US Oncology Research 10
Testing effectiveness (Phase 2)Study completedNCT01849250
What this trial is testing

Study of Docosahexaenoic Acid (DHA) in Triple Negative Breast Cancer Survivors

Who this might be right for
Benign Breast NeoplasmDuctal Breast Carcinoma In SituInvasive Breast Carcinoma+9 more
National Cancer Institute (NCI) 65
Early research (Phase 1)Active Not RecruitingNCT05082259
What this trial is testing

ASTEROID: A Trial of ASTX660 in Combination With Pembrolizumab

Who this might be right for
Advanced CancerCervical CancerTriple Negative Breast Cancer
Institute of Cancer Research, United Kingdom 61
Next Page